Cargando…
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum
Autores principales: | Zhang, Qian-Qian, Ding, Yi, Lei, Yan, Qi, Cui-Ling, He, Xiao-Dong, Lan, Tian, Li, Jiang-Chao, Gong, Ping, Yang, Xuesong, Geng, Jian-Guo, Wang, Li-Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378650/ https://www.ncbi.nlm.nih.gov/pubmed/32760205 http://dx.doi.org/10.7150/ijbs.49433 |
Ejemplares similares
-
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
por: Zhang, Qian-Qian, et al.
Publicado: (2014) -
Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Publicado: (2021) -
Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”
por: Han, Chenglin, et al.
Publicado: (2021) -
Inflammatory extracellular vesicles prompt heart dysfunction via TLR4-dependent NF-κB activation: Erratum
por: Biemmi, Vanessa, et al.
Publicado: (2023) -
Erratum to “NF-κB Signaling in the Brain of Autistic Subjects”
por: Malik, Mazhar, et al.
Publicado: (2013)